News by Tag: Heart Patients
J&J and Bayer's drug Xarelto fails to impress FDA
June 28, 2012
The market for the drugs related to heart complications is very vast resulting in a huge rise in the financial growth of the company. The approval of Xarelto for acute coronary syndrome cure by FDA may have resulted in a strong competition.
June 28, 2012
The market for the drugs related to heart complications is very vast resulting in a huge rise in the financial growth of the company. The approval of Xarelto for acute coronary syndrome cure by FDA may have resulted in a strong competition.